TL;DR
Researchers have determined the high-resolution cryo-EM structure of the orphan G protein-coupled receptor GPR21, revealing its active conformation coupled to the Gαs protein. This breakthrough provides crucial structural insights into GPR21's role in type 2 diabetes and identifies its extracellular loop 2 (ECL2) as a key player in its constitutive activation and signaling.
What Problem Does This Paper Address?
G protein-coupled receptors (GPCRs) are a vast family of cell surface receptors involved in numerous physiological processes and are major drug targets. However, many GPCRs, known as "orphan" receptors, lack identified endogenous ligands, making their function and therapeutic potential difficult to decipher. GPR21 is one such orphan GPCR, implicated in type 2 diabetes (T2DM) due to its association with insulin resistance and metabolic dysfunction. While previous studies suggested GPR21 might be constitutively active and potentially signal through Gαq, the precise structural mechanisms underlying its activation and its interaction with G proteins remained unknown. This lack of structural information hindered the development of targeted therapies for T2DM.
Methods
The core technique employed was cryo-electron microscopy (cryo-EM) coupled with single-particle analysis. This allowed the researchers to visualize the GPR21-G protein complex at near-atomic resolution. Specifically:
- Protein Expression and Purification: Wild-type GPR21 was expressed in Spodoptera frugiperda (Sf9) insect cells, fused with a BRIL tag to enhance expression. It was then co-expressed with a dominant-negative Gαs protein (DNGαs), along with Gβ1 and Gγ2 subunits, to stabilize the complex. A nanobody (Nb35) was also used to further stabilize the G protein complex for imaging.
- Cryo-EM Data Acquisition: Grids containing the purified complex were flash-frozen, and images were collected using a 300 kV Titan Krios cryo-EM microscope.
- Image Processing and 3D Reconstruction: Standard cryo-EM processing pipelines (using software like CryoSPARC) were used to correct for motion, estimate CTF, classify particles, and reconstruct a 3D density map of the GPR21-Gαs complex.
- Model Building and Refinement: The initial model for GPR21 was generated using AlphaFold, and models for the G protein and nanobody were based on existing structures. These were then docked into the cryo-EM density map and refined using software like UCSF Chimera and Phenix.
- Structure-Guided Mutagenesis and Biochemical Assays: To investigate the role of specific regions, particularly extracellular loop 2 (ECL2), researchers generated mutants by replacing parts of ECL2 with flexible GS linkers. The functional impact of these mutations on downstream signaling was assessed using cAMP accumulation assays (measured via HTRF) and flow cytometry to evaluate surface expression levels.
Datasets
The primary dataset used was the cryo-EM data collected for the GPR21-DNGαs-Nb35 complex. The resulting 3D density map and atomic coordinates of the GPR21-Gs complex have been deposited in the Protein Data Bank (PDB) under accession code 8HMV and the Electron Microscopy Database (EMDB) under accession code EMD-34903.
The paper also references existing PDB structures for comparison:
- apo-GPR52 (PDB: 6LI1 and 6LI2)
- mini-Gs-coupled GPR52 (PDB: 6LI3)
- β2AR (PDB: 3SN6)
- corticotropin-releasing factor 1 receptor-Gs-Nb35 complex (PDB: 6PB0)
Key Insights and Ideas
- GPR21 Couples to Gαs: Contrary to previous suggestions of Gαq coupling, this study provides direct structural evidence that GPR21 can form a stable complex with the Gαs protein. This suggests GPR21 may signal through the cAMP pathway, which is relevant to metabolic regulation.
- Active Conformation Revealed: The cryo-EM structure captures GPR21 in an active conformation, characterized by the outward displacement of transmembrane helix 6 (TM6), a hallmark of activated class A GPCRs. This provides a structural basis for its potential constitutive activity.
- ECL2 as a "Built-in Ligand": The extracellular loop 2 (ECL2) of GPR21 is uniquely positioned, with a submerged "immersed region" and a "cap region," to occupy the orthosteric ligand-binding pocket. This suggests ECL2 acts as an intrinsic modulator, contributing to GPR21's constitutive activation, even in the absence of external ligands.
- ECL2 is Crucial for Gαs Signaling: Mutagenesis studies confirm that ECL2 is essential for GPR21 to transduce intracellular signals via Gαs, specifically through cAMP accumulation. Disrupting ECL2 significantly abrogates this signaling.
- Structural Similarities to GPR52: GPR21 shares significant sequence identity with GPR52, and their structures show high similarity, particularly in the conserved motifs and the ECL2 region. This highlights potential shared mechanisms of activation and regulation between these orphan receptors.
Key Results
- High-Resolution Structure: The cryo-EM analysis yielded a high-resolution structure of the GPR21-Gαs complex at 2.91 Å resolution.
- ECL2's Role in cAMP Signaling: Replacing ECL2 with a flexible GS linker significantly abrogated cAMP accumulation mediated by Gαs, demonstrating ECL2's critical role in GPR21 activation.
- Structural Comparison: The GPR21 structure showed high conformational similarity to mini-Gs-coupled GPR52, with a root mean squared deviation (r.m.s.d.) of 1.032 Å.
- Conserved Motifs: Comparisons of conserved motifs (transmission switch, PMF domain, sodium pocket, NPxxY domain, DRY domain) indicated that GPR21 adopts an active conformation, similar to active GPR52.
Limitations and Future Work
- Ligand Identification: While the study reveals structural insights into GPR21's activation and G protein coupling, the endogenous ligand for GPR21 remains unidentified. This is a persistent challenge for orphan GPCRs.
- Gαq Coupling: Although the study focused on Gαs coupling, previous work suggested GPR21 might also couple to Gαq. The paper notes that a stable GPR21-Gαq complex could not be purified, leaving the precise mechanisms and context of Gαq signaling for GPR21 open for further investigation.
- Therapeutic Implications: The authors suggest that the structural data provides a fundamental basis for structure-based drug development. Future work could focus on designing modulators that target the unique features of GPR21, such as its ECL2 region or allosteric sites, to treat T2DM. The paper also highlights the potential for targeting the cAMP/PKA pathway, which is influenced by GPR21-Gαs signaling, for glycemic control.
- Context-Dependent Signaling: The authors acknowledge that G protein coupling preference might be context-dependent, as Gαq signaling has been reported in macrophages, while this study focused on Gαs. Further research could explore these different signaling pathways and their cellular contexts.
Summary updated